NCT06892847 Brain STimulation for ANxiety and Depression in Youth
| NCT ID | NCT06892847 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Calgary |
| Condition | Anxiety Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2025-07-01 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this open-label trial, the overall aim is to determine if TMS treatment can improve anxiety and depression in a broad group of children and youth referred by physicians.
Eligibility Criteria
Inclusion Criteria: 1. aged between 6 and 18 years old 2. diagnosis of anxiety or depression made by a qualified medical professional 3. active anxiety and/or depression symptoms Exclusion Criteria: 1. status epilepticus in past 12-months 2. presence of any disease, medical condition, or physical condition that, in the opinion of the study investigator may compromise, interfere, limit, affect, or reduce the participant's ability to complete the study 3. hospitalization for suicide attempt within the past 3 months (unless participant is under the daily supervision of a physician, such as in a mental health day treatment program) 4. TMS-related contraindications, including implanted medical devices (e.g., pacemaker) 5. if actively taking prescription medication, no changes in medication for at least 3 months prior to entry into the study, with no anticipation of change in the frequency or dose over the duration of the study, unless changes to medication are required for participant safety 6. unable to understand instructions in English
Contact & Investigator
Kara Murias, MD/PhD
PRINCIPAL INVESTIGATOR
The University of Calgary
Frequently Asked Questions
Who can join the NCT06892847 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 18 Years, studying Anxiety Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06892847 currently recruiting?
Yes, NCT06892847 is actively recruiting participants. Contact the research team at krmarten@ucalgary.ca for enrollment information.
Where is the NCT06892847 trial being conducted?
This trial is being conducted at Calgary, Canada.
Who is sponsoring the NCT06892847 clinical trial?
NCT06892847 is sponsored by University of Calgary. The principal investigator is Kara Murias, MD/PhD at The University of Calgary. The trial plans to enroll 120 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.